Virginia 2025 Regular Session

Virginia Senate Bill SB1483 Compare Versions

OldNewDifferences
11 2025 SESSION
22
3-ENGROSSED
3+LEGISLATION NOT PREPARED BY DLS
4+
5+INTRODUCED
46
57 25105327D
68
79 SENATE BILL NO. 1483
810
9-Senate Amendments in [ ] - January 31, 2025
11+Offered January 17, 2025
1012
1113 A BILL to amend and reenact 3.2-4122 of the Code of Virginia, relating to regulated hemp product retail facility registration; fee.
1214
1315
1416
15-Patrons Prior to EngrossmentSenators Boysko and Salim
17+PatronBoysko
1618
1719
1820
1921 Referred to Committee on Rehabilitation and Social Services
2022
2123
2224
2325 Be it enacted by the General Assembly of Virginia:
2426
2527 1. That 3.2-4122 of the Code of Virginia is amended and reenacted as follows:
2628
2729 3.2-4122. (Effective November 15, 2024) Regulated hemp product retail facility registration; fee.
2830
2931 A. No person shall offer for sale or sell at retail (i) a regulated hemp product or (ii) a substance intended for human consumption, orally or by inhalation, that is advertised or labeled as containing an industrial hemp-derived cannabinoid without a regulated hemp product retail facility registration.
3032
3133 B. A nonrefundable annual registration fee of $1,000 shall be required with each application for a regulated hemp product retail facility registration.
3234
3335 C. Each registration issued pursuant to this section shall be valid for a period of one year from the date of issuance and may be renewed in successive years. Each annual renewal shall require the payment of the nonrefundable annual registration fee prescribed in subsection B.
3436
3537 D. A regulated hemp product retail facility registration shall be required for each the primary location that offers for sale or sells at retail regulated hemp products. A registration shall authorize the offering for sale or sale of regulated hemp products at the location specified in the registration;
3638
37-E. The applicant shall be required to notify the Commissioner no less than 14 days in advance of any additional temporary event locations, including fairs, festivals, or farmers markets, at which the hemp product retail facility intends to offer for sale or sell at retail (i) a regulated hemp product or (ii) a substance intended for human consumption, orally or by inhalation, that is advertised or labeled as containing an industrial hemp-derived cannabinoid. [ However, no such product or substance that contains tetrahydrocannabinol may be sold at any such temporary event location. ]
39+E. The applicant shall be required to notify the Commissioner no less than 14 days in advance of any additional temporary event locations, including fairs, festivals, or farmers markets, at which the hemp product retail facility intends to offer for sale or sell at retail (i) a regulated hemp product or (ii) a substance intended for human consumption, orally or by inhalation, that is advertised or labeled as containing an industrial hemp-derived cannabinoid.
3840
3941 E. F. Any person seeking a regulated hemp product retail facility registration shall apply to the Commissioner on a form provided by the Commissioner. At a minimum, the application shall include:
4042
4143 1. The name and mailing address of the applicant;
4244
4345 2. The physical address of the facility from which the applicant intends to offer for sale or sell at retail a regulated hemp product. A registration shall authorize the offering for sale or sale of regulated hemp products only at the location specified in the registration;
4446
4547 3. Written consent allowing the Commissioner or his designee to enter the location from which the regulated hemp product is offered for sale or sold to ensure compliance with the requirements of this article;
4648
4749 4. If the applicant intends to offer for sale or sell an edible hemp product, a copy of the permit issued by the Commissioner pursuant to 3.2-5100;
4850
4951 5. Any other information required by the Commissioner; and
5052
5153 6. The payment of a nonrefundable application fee.
5254
5355 F. G. This section shall not apply to products that are (i) approved for marketing by the U.S. Food and Drug Administration and scheduled in the Drug Control Act ( 54.1-3400 et seq.) or (ii) dispensed pursuant to Article 4.2 ( 54.1-3442.5 et seq.) of the Drug Control Act.